Follow the Greater Cannabis Company, Inc. share price and the full directors' dealings record of the company, a publicly traded company based in United States. Shares are listed on the US market, under the oversight of SEC (Form 4). Market capitalisation: €2.2bn. The latest transaction was filed on 8 April 2025 (Attribution). Among the most active insiders: Sapir LLC. Every trade is openly available.
Analysts rate Greater Cannabis Company, Inc. Strong Buy (bullish), based on 12 analysts. Average price target: US$59.30.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Greater Cannabis Company, Inc. is a company listed on the XNAS market, specializing in the cannabis sector. It focuses on the development and marketing of cannabis-related products.